| Verifiedfields | changed |
|---|---|
| Watchedfields | changed |
| Verifiedrevid | 444411745 |
| Iupac name | 2-[12-(oxiran-2-yl)-2,5,8,11-tetraoxadodecan-1-yl]oxirane |
| Cas number | 1954-28-5 |
| Atc prefix | L01 |
| Atc suffix | AG01 |
| Chembl | 460287 |
| Pubchem | 16058 |
| Unii | 4F9KUA0T4D |
| Kegg | D07256 |
| Chemspiderid | 15246 |
| Smiles | O(CCOCCOCC1OC1)CCOCC2OC2 |
| Stdinchi | 1S/C12H22O6/c1(13-3-5-15-7-11-9-17-11)2-14-4-6-16-8-12-10-18-12/h11-12H,1-10H2 |
| Stdinchikey | UMILHIMHKXVDGH-UHFFFAOYSA-N |
| C | 12 |
| H | 22 |
| O | 6 |
| Synonyms | Diglycidyltriethylene glycol |
Etoglucid is a drug used in chemotherapy.[1] It is an epoxide compound.[2]
References
- ^ Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L (March 1994). "[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study]" (in German). Urologe A. 33 (2): 138–43. PMID 8178408
- ^ PubChem. "Etoglucid". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-03-02.